An2 Therapeutics, Inc. (ANTX)

$2.11

+0.04

(+1.93%)

Market is closed - opens 7 PM, 24 Jun 2024

Performance

  • $2.01
    $2.14
    $2.11
    downward going graph

    4.74%

    Downside

    Day's Volatility :6.07%

    Upside

    1.4%

    downward going graph
  • $1.91
    $22.22
    $2.11
    downward going graph

    9.48%

    Downside

    52 Weeks Volatility :91.4%

    Upside

    90.5%

    downward going graph

Returns

PeriodAn2 Therapeutics, Inc.
3 Months
-37.84%
6 Months
-89.62%
1 Year
-70.64%
3 Years
-86.56%

Highlights

Market Capitalization
61.7M
Book Value
$3.71
Earnings Per Share (EPS)
-2.51
Wall Street Target Price
12.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-42.32%
Return On Equity TTM
-68.38%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-2.51
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-2.43
EPS Estimate Next Year
-2.38
EPS Estimate Current Quarter
-0.62
EPS Estimate Next Quarter
-0.63

Analyst Recommendation

Buy
    72%Buy
    27%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for An2 Therapeutics, Inc.(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
10
Hold
3
4
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 468.72%

Current $2.11
Target $12.00

Technicals Summary

Sell

Neutral

Buy

An2 Therapeutics, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
An2 Therapeutics, Inc.
An2 Therapeutics, Inc.
-4.39%
-89.62%
-70.64%
-86.56%
-86.56%
Moderna, Inc.
Moderna, Inc.
-17.71%
41.64%
11.55%
-39.28%
857.26%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
5.07%
24.05%
34.11%
95.48%
226.11%
Novo Nordisk A/s
Novo Nordisk A/s
5.19%
37.27%
76.22%
243.21%
449.78%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.73%
15.66%
34.62%
148.17%
158.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
An2 Therapeutics, Inc.
An2 Therapeutics, Inc.
NA
NA
NA
-2.43
-0.68
-0.42
NA
3.71
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.2
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
30.68
30.68
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
49.23
49.23
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
30.3
30.3
0.53
17.09
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
An2 Therapeutics, Inc.
An2 Therapeutics, Inc.
Buy
$59.7M
-86.56%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$51.1B
857.26%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$114.5B
226.11%
30.68
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$629.2B
449.78%
49.23
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
158.93%
30.3
39.46%

Institutional Holdings

  • RA Capital Management, LLC

    18.61%
  • TCG Crossover Management, LLC

    5.21%
  • Bvf Inc

    4.16%
  • HHG PLC

    4.09%
  • Avidity Partners Management LP

    3.86%
  • Octagon Capital Advisors LP

    3.70%

Company Information

an2 therapeutics, inc. is a california-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. an2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for new treatments that can save lives across the globe. founded by a small team of biopharmaceutical industry leaders with a passion for global health and experience in infectious disease drug r&d, we strive to bring patients treatments that will restore their health and enable them to live productive lives.

Organization
An2 Therapeutics, Inc.
Employees
41
CEO
Mr. Joseph S. Zakrzewski
Industry
Services

FAQs